gma glp 1 Drugmaker Eli Lilly has released promising trial data for its oral GLP-1 weight loss pill. Dr. Darien Sutton reports on what the company is saying about its effectiveness. | Good Morning America New analysis of GLP-1 drugs
Description
Andreas Menke "Feel good, live better" In this episode of the podcast, Dr

1 First session Scheduled within your first 14 days on treatment to help you start strong
Foods rich in fiber, protein, and healthy fats naturally trigger endogenous GLP-1 increase
Affects roughly 20-30% of users, with the highest incidence during dose escalation phases

These medications affect brain reward pathways that process food pleasure and cause delayed gastric emptying, which can create food aversions and alter taste perception
Its key challenge is clear: we have many biomarkers, but still lack a practical way to integrate them into personalized nutritional care
